Predictive Oncology Inc. (POAI)
NASDAQ: POAI · Real-Time Price · USD
1.550
+0.280 (22.05%)
Jan 22, 2025, 2:07 PM EST - Market open
Predictive Oncology Employees
As of December 31, 2023, Predictive Oncology had 35 total employees, including 34 full-time and 1 part-time employees. The number of employees increased by 1 or 2.94% compared to the previous year.
Employees
35
Change (1Y)
1
Growth (1Y)
2.94%
Revenue / Employee
$42,406
Profits / Employee
-$399,147
Market Cap
10.33M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
POAI News
- 6 days ago - Predictive Oncology Announces Planned European Launch of its ChemoFx® Treatment Selection Marker and Tumor Profiling Assay - GlobeNewsWire
- 14 days ago - PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI - Business Wire
- 16 days ago - Predictive Oncology Announces Agreement to be Acquired by Renovaro - GlobeNewsWire
- 2 months ago - Predictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update - GlobeNewsWire
- 4 months ago - Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 5 months ago - Predictive Oncology Inc. (POAI) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Predictive Oncology Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 6 months ago - Predictive Oncology to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024 - GlobeNewsWire